Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial. [electronic resource]
Producer: 20150206Description: R38 p. digitalISSN:- 1465-542X
- Antineoplastic Agents, Hormonal -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant
- Clinical Trials, Phase III as Topic
- Cyclophosphamide -- administration & dosage
- Epirubicin -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Humans
- Lymphatic Metastasis
- Multicenter Studies as Topic
- Outcome Assessment, Health Care -- methods
- Paclitaxel -- administration & dosage
- Prospective Studies
- Randomized Controlled Trials as Topic
- Receptor, ErbB-2 -- metabolism
- Receptors, Estrogen -- metabolism
- Reproducibility of Results
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article; Validation Study
There are no comments on this title.
Log in to your account to post a comment.